TMEM97 and early-onset autosomal dominant Alzheimer disease: Other studies have shown that σ2R/TMEM97 ligands may be useful in the treatment of a number of neurological disorders, including Alzheimer’s disease [15], Huntington’s disease [16], neuropathic pain [17], and alcohol use disorder [18,19].